Panagiotis Prinos appointed as Director of R茅seau DePTAQ
好色TV, the Institut de recherches cliniques de Montr茅al (IRCM) and Universit茅 de Sherbrooke, partners in the RNA Network for Therapy Development & Production (R茅seau DePTAQ), are pleased to announce the appointment of Panagiotis (Takis) Prinos, PhD, as Director of R茅seau DePTAQ.
To enhance Quebec鈥檚 world-leadership in biomedical and biopharmaceutical research in RNA therapies, R茅seau DePTAQ provides academic researchers and industrial partners with a single interface and specialized services for the development and production of RNA therapies through three platforms: the IRCM鈥檚 Sidney-Altman RNA Therapeutic Hub, the Therapeutic messenger RNA platform at 好色TV鈥檚 Centre for RNA Sciences, and Sherbrooke University鈥檚 RNomic Platform.
As Director, Mr. Prinos will oversee and elevate the R茅seau DePTAQ鈥檚 service platforms while fostering interdisciplinary collaborations across Quebec and Canada. He will also lead business development and industry liaison efforts.
An accomplished biomedical scientist and strategic manager with over 15 years of experience leading innovative cancer genomics and personalized medicine projects, Mr. Prinos previously served as Team Leader of Epigenetics Cellular Screening at the Structural Genomics Consortium (SGC) at the University of Toronto, and Director of the Phenotypic Platform at L鈥橴niversit茅 de Sherbrooke. Mr. Prinos鈥檚 extensive experience managing cross-functional teams and resources and his skills in building strong stakeholder relationships underscores his unique qualifications for this important position.
Please join us in welcoming him to R茅seau DePTAQ!
R茅seau DePTAQ is funded by the Government of Quebec and the three partners, as well as by 好色TVl's DNA to RNA (D2R) research initiative. DePTAQ is one of five strategic initiatives of , Quebec's RNA cluster. Launched by the Minist猫re de l'脡conomie, de l'Innovation et de l'脡nergie (MEIE), AReNA's mission is to strengthen and raise the profile of the RNA-based therapies industry, and to create a dynamic ecosystem around RNA therapies in Quebec, contributing to its international profile.
听
